Statistical methods and molecular docking for the prediction of thyroid hormone receptor subtype binding affinity and selectivity

Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097–1142 Aranda A, Pascual A (2001) Nuclear hormone receptors and gene expression. Physiol Rev 81:1269–1304 Malm J (2004) Thyroid hormone ligands and metabolic diseases. Curr Pharm Des 10:3525–3532 Yen PM, Ando S, Xu F, Ying L, Maruvada P, Xia X (2006) Thyroid hormone action at the cellular, genomic and target gene levels. Molecular & Cellular Endocrinology 246:121–127 Zhang J, Lazar MA (2000) The mechanism of action of thyroid hormones. Br J Clin Pharmacol 62:439–466 Chan IH, Privalsky ML (2009) Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1. Mol Endocrinol 23:1758–1775 Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennström B, Samarut J (2006) International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 58:705–711 Wu Y, Koenig RJ (2000) Gene regulation by thyroid hormone. Trends in Endocrinology & Metabolism Tem 11:207–211 Bassett JHD, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular & Cellular Endocrinology 213:1–11 Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK (2009) Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. American Journal of Physiology Endocrinology & Metabolism:297 Forrest D, Vennström B (2000) Functions of thyroid hormone receptors in mice. Thyroid Official Journal of the American Thyroid Association 10:41–52 Nguyen NH, Apriletti JW, Baxter JD, Scanlan TS (2005) Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists. J Am Chem Soc 127:4599–4608 Johansson C, Vennström B, Thorén P (1998) Evidence that decreased heart rate in thyroid hormone receptor-alpha1-deficient mice is an intrinsic defect. Am J Phys 275:640–646 Takeda K, Sakurai A, Degroot LJ, Refetoff S (1992) Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. Journal of Clinical Endocrinology & Metabolism 74:49–55 Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS (2001) Selective modulation of thyroid hormone receptor action ☆. Journal of Steroid Biochemistry & Molecular Biology 76:31–42 Collazo A-MG, Koehler KF, Garg N, Färnegårdh M, Husman B, Ye L, Ljunggren J, Mellström K, Sandberg J, Grynfarb M (2006) Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor β. Bioorg Med Chem Lett 16:1240–1244 Garg N, Li Y-L, Collazo AMG, Litten C, Ryono DE, Zhang M, Caringal Y, Brigance RP, Meng W, Washburn WN (2007) Thyroid receptor ligands. Part 8: thyromimetics derived from N-acylated-α-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141. Bioorg Med Chem Lett 17:4131–4134 Hangel JJ, Al E, et al. (2004) Thyroid receptor ligands. Part 2: thyromimetics with improved selectivity for the thyroid hormone receptor beta. Bioorg Med Chem Lett 14:3549–3553 Hedfors A, Appelqvist T, Carlsson B, Bladh LG, Litten C, Agback P, Grynfarb M, Koehler KF, Malm J (2005) Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor. J Med Chem 48:3114–3117 Li Y-L, Litten C, Koehler KF, Mellström K, Garg N, Collazo AMG, Färnegård M, Grynfarb M, Husman B, Sandberg J (2006) Thyroid receptor ligands. Part 4: 4′-amido bioisosteric ligands selective for the thyroid hormone receptor beta. Bioorg Med Chem Lett 16:884–886 Malm J, Gordon S, Brandt P, Carlsson B, Agback P, Saeidi AB, Sandberg J (2007) Thyroid receptor ligands. Part 7: indirect antagonists of the thyroid hormone receptor with improved affinity. Bioorg Med Chem Lett 17:2018–2021 Ye L , Li YL, Mellström K, Mellin C, Bladh LG, Koehler K, Garg N, Collazo AMG, Litten C, Husman B (2003) Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor β1. J Med Chem 46:1580–1588 Boyer SH, Jiang H, Jacintho JD, Reddy MV, Li H, Li W, Godwin JL, Schulz WG, Cable EE, Hou J (2008) Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs. J Med Chem 51:7075–7093 Burkholder TP, Cunningham BE, Clayton JR, Lander PA, Brown ML, Doti RA, Durst GL, Montrose-Rafizadeh C, King C, Osborne HE (2015) Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists. Bioorg Med Chem Lett 25:1377–1380 Shiohara H, Nakamura T, Kikuchi N, Ozawa T, Nagano R, Matsuzawa A, Ohnota H, Miyamoto T, Ichikawa K, Hashizume K (2012) Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. Bioorg Med Chem 20:3622–3634 Shiohara H, Nakamura T, Kikuchi N, Ozawa T, Matsuzawa A, Nagano R, Ohnota H, Miyamoto T, Ichikawa K, Hashizume K (2013) Design, synthesis, and structure–activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl] malonamic acids as thyroid hormone receptor β (TRβ) selective agonists. Bioorg Med Chem 21:592–607 Todeschini, R., Consonni, V., (2000). Handbook of molecular descriptors Wang F, Li Y, Ma Z, Wang X, Wang Y (2012) Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics. J Mol Model 18:295–306 Wang F, Ma Z, Li Y, Zhu S, Xiao Z, Zhang H, Wang Y (2011) Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. J Mol Graph Model 30:67–81 Wang Y, Li Y, Ding J, Wang Y, Chang Y (2008b) Prediction of binding affinity for estrogen receptor α modulators using statistical learning approaches. Mol Divers 12:93–102 Wang Y, Li Y, Ding J, Jiang Z, Chang Y (2008a) Estimation of bioconcentration factors using molecular electro-topological state and flexibility. SAR QSAR Environ Res 19:375–395 Hansch, C., Leo, A., (1979). Substituent constants for correlation analysis in chemistry and biology. Wiley Sjöström M, Wold S, Lindberg W, Persson J-Å, Martens H (1983) A multivariate calibration problem in analytical chemistry solved by partial least-squares models in latent variables. Anal Chim Acta 150:61–70 Ding G, Chen J, Qiao X, Huang L, Lin J, Chen X (2006) Quantitative relationships between molecular structures, environmental temperatures and solid vapor pressures of PCDD/Fs. Chemosphere 62:1057–1063 Wold S, Sjöström M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst 58:109–130 Wold S, Ruhe A, Wold H, Dunn III WJ (1984) The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5:735–743 Liu H, Xue C, Zhang R, Yao X, Liu M, Hu Z, Fan BT (2004) Quantitative prediction of log k of peptides in high-performance liquid chromatography based on molecular descriptors by using the heuristic method and support vector machine. J Chem Inf Comput Sci 44:1979–1986 Xue C, Zhang R, Liu H, Yao X, Liu M, Hu Z, Fan BT (2004) QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine. J Chem Inf Comput Sci 44:1693–1700 Smola AJ, Schölkopf B (2004) A tutorial on support vector regression. Stat Comput 14:199–222 Kohonen T, Somervuo P (1998) Self-organizing maps of symbol strings. Neurocomputing 21:19–30 Jaworska J (2005) QSAR applicability domain estimation by projection of the training set in descriptor space: a review. Alternatives to Laboratory Animals Atla 33:445–459 Roy K, Kar S, Ambure P (2015) On a simple approach for determining applicability domain of QSAR models. Chemometrics & Intelligent Laboratory Systems 145:22–29 Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662 Patronov A, Dimitrov I, Flower DR, Doytchinova I (2011) Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach. BMC Struct Biol 11:1 Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner P (1984) A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 106:765–784 Guha R, Serra JR, Jurs PC (2004) Generation of QSAR sets with a self-organizing map. J Mol Graph Model 23:1–14 Jain HK, Agrawal RK (2006) QSAR analysis of indomethacin derivatives as selective COX–2 inhibitors. Internet Electronic Journal of Molecular Design 5:224–236 Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717 Khajeh A, Modarress H (2012) QSPR prediction of surface tension of refrigerants from their molecular structures. Int J Refrig 35:150–159 Manivannan E, Chaturvedi S (2012) Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2, 3-diaryl-2, 3-dihydro-1H-quinazolin-4-ones. Bioorg Med Chem 20:7119–7127 MacKay DJ (1992) A practical Bayesian framework for backpropagation networks. Neural Comput 4:448–472 Salum LB, Polikarpov I, Andricopulo AD (2008) Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity. J Chem Inf Model 48:2243–2253 Schölkopf, B., Burges, C. J., (1999). Advances in kernel methods: support vector learning. MIT press Schuur J, Gasteiger J (1997) Infrared spectra simulation of substituted benzene derivatives on the basis of a 3D structure representation. Anal Chem 69:2398–2405 Todeschini R, Gramatica P (2001) New 3D molecular descriptors: the WHIM theory and QSAR applications. Perspectives in Drug Discovery & Design 9-11:355–380 Todeschini R, Gramatica P (1997a) 3D-modelling and prediction by WHIM descriptors. Part 6. Application of WHIM descriptors in QSAR studies. Quantitative Structure-Activity Relationships 16:120–125 Todeschini R, Gramatica P (1997b) SD-modelling and prediction by WHIM descriptors. Part 5. Theory development and chemical meaning of WHIM descriptors. Quantitative Structure-Activity Relationships 16:113–119 Todeschini R, Lasagni M, Marengo E (1994) New molecular descriptors for 2D and 3D structures. Theory Journal of chemometrics 8:263–272 Todeschini R, Gramatica P, Provenzani R, Marengo E (1995) Weighted holistic invariant molecular descriptors. Part 2. Theory development and applications on modeling physicochemical properties of polyaromatic hydrocarbons. Chemom Intell Lab Syst 27:221–229 Todeschini R, Vighi M, Finizio A, Gramatica P (1997) 30-modelling and prediction by WHIM descriptors. Part 8. Toxicity and physico-chemical properties of environmental priority chemicals by 2D-TI and 3D-WHIM descriptors. SAR QSAR Environ Res 7:173–193 Todeschini R, Vighi M, Provenzani R, Finizio A, Gramatica P (1996a) Modeling and prediction by using WHIM descriptors in QSAR studies: toxicity of heterogeneous chemicals on Daphnia magna. Chemosphere 32:1527–1545 Todeschini R, Bettiol C, Giurin G, Gramatica P, Miana P, Argese E (1996b) Modeling and prediction by using WHIM descriptors in QSAR studies: submitochondrial particles (SMP) as toxicity blosensors of chlorophenols. Chemosphere 33:71–79 Vedani A, Dobler M, Lill MA (2006) The challenge of predicting drug toxicity in silico. Basic & clinical pharmacology & toxicology 99:195–208 Vedani A, Zumstein M, Lill MA, Ernst B (2007) Simulating α/β selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR. ChemMedChem 2:78–87 Du J, Qin J, Liu H, Yao X (2008) 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor β. J Mol Graph Model 27:95–104 Li F, Xie Q, Li X, Li N, Chi P, Chen J, Wang Z, Hao C (2010) Hormone activity of hydroxylated polybrominated diphenyl ethers on human thyroid receptor-β: in vitro and in silico investigations. Environmental health perspectives (Online) 118:602 Kim KH, Greco G, Novellino E (1998) A critical review of recent CoMFA applications. In: Kubinyi H, Folkers G, Martin YC (eds) 3D QSAR in drug design – recent advances, vol. 3. Kluwer Academic Publishers, New York, pp. 257–315 Sutherland JJ, O'Brien LA, Weaver DF (2004) A comparison of methods for modeling quantitative structure-activity relationships. J Med Chem 47:5541–5554 Kuntz ID, Meng EC, Shoichet BK (1994) Structure-based molecular design. Acc Chem Res 27:117–123 Wang FF, Wei Y, Shi YH, Cheng XR, Le GW (2015) Structure-based approach for the study of thyroid hormone receptor binding affinity and subtype selectivity. J Biomol Struct Dyn 34:2251–2267